EurekAlert! News by Subject: Medicine & Health

Medicine & Health

Updates every hour. Last Updated: 25-Oct-2026 10:17 ET (25-Oct-2026 14:17 GMT/UTC)

13-Oct-2026

Targeting PLA2G15 reduces senescence and alters lipid metabolism in kidney cells

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — October 13, 2026 — A new research paper was published in Volume 18 of Aging on September 16, 2026, titled “Targeting phospholipase Pla2g15 reduces long-chain BMP phospholipids abundance and senescence in kidney cells.”

Journal: Aging-US

13-Oct-2026

Decades of work by husband-and-wife team yields new Parkinson's drug

University of Virginia Health System
Business Announcement

The drug could offer a "second honeymoon" for patients for whom the existing gold-standard Parkinson's treatment has stopped working.

13-Oct-2026

Treating life-threatening blood clots in minutes with swirling sound waves

University of Michigan
Grant and Award Announcement

For a faster, safer way to treat pulmonary embolism—potentially deadly blood clots stuck in the lungs—engineers and vascular surgeons are joining forces to develop a minimally invasive "vortex ultrasound" device.

13-Oct-2026

AI-driven molecular glue innovation: Insilico nominates ISM9546, an oral, peripheral-restricted VAV1 degrader as PCC for autoimmune diseases

InSilico Medicine
Business Announcement

Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage drug discovery company powered by generative artificial intelligence (AI), today announced the nomination of ISM9546, an orally bioavailable, peripheral-restricted VAV1 molecular glue degrader for the potential treatment of autoimmune diseases including IBD (inflammatory bowel disease) and RA (rheumatoid arthritis). Empowered by Insilico’s proprietary Pharma.AI solution, ISM9546 not only marks the 35^th PCC nomination of the company since 2021, but also strikes a balance between efficacy and safety, with nanomolar activity validated across cell assays, and peripherally restricted trait to alleviate risks related to the CNS (central nervous system).

13-Oct-2026

Long-term viral hepatitis control and changing patterns of liver cancer mortality in Japan

Hiroshima University
Peer-Reviewed Publication

Over decades of sustained, integrated national viral hepatitis control, Japan has seen substantial reductions in HBV- and HCV-related disease burden and hepatocellular carcinoma mortality.

Journal: The Lancet Regional Health - Western Pacific
Funder: Ministry of Health, Labour and Welfare, Japan

13-Oct-2026

PMOS/PCOS may be linked to Alzheimer's disease and dementia

The Endocrine Society
Peer-Reviewed Publication

Alzheimer’s disease and dementia may be more common in women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), according to a review of existing evidence published in the Journal of the Endocrine Society.

Journal: Journal of the Endocrine Society

13-Oct-2026

Even highly curable childhood cancers take a substantial toll on families, according to new study from JNCCN

National Comprehensive Cancer Network
Peer-Reviewed Publication

More than 4 out of 5 families experiencing treatment for childhood leukemia were impacted by employment or marital status changes during care according to new research in JNCCN.

Journal: Journal of the National Comprehensive Cancer Network

13-Oct-2026

ACLM launches two solutions to advance nutrition and lifestyle medicine education, helping meet federal and state requirements

American College of Lifestyle Medicine
Business Announcement

A new turnkey medical school curriculum and an updated food as medicine continuing education course will help medical schools meet emerging federal nutrition education requirements and help practicing physicians and other clinicians integrate evidence-based education relevant to state-level nutrition education requirements.A new turnkey medical school curriculum and an updated food as medicine continuing education course will help medical schools meet emerging federal nutrition education requirements and help practicing physicians and other clinicians integrate evidence-based education relevant to state-level nutrition education requirements.

13-Oct-2026

Abstract featuring Bronchiectasis and NTM Research Registry data to be presented at CHEST 2026

COPD Foundation
Reports and Proceedings

The Bronchiectasis and NTM Association announced today that an abstract using Bronchiectasis and NTM Research Registry data will be presented as a rapid-fire presentation at CHEST 2026, held October 18-21, 2026, in Phoenix.